{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:39:58Z","timestamp":1792802398381,"version":"4.5.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T00:00:00Z","timestamp":1488153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u00c5land Cultural Foundation"},{"name":"The Selander Foundation","id":[{"id":"https:\/\/ror.org\/00kmptt33","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0172762","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T13:44:03Z","timestamp":1488203043000},"page":"e0172762","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":60,"title":["Tau or neurofilament light\u2014Which is the more suitable biomarker for Huntington\u2019s disease?"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2576-9938","authenticated-orcid":true,"given":"Valter","family":"Niemel\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Landtblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Sundblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,2,27]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"CA Ross","year":"2014","journal-title":"Nature reviews Neurology"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.31887\/DCNS.2016.18.1\/pnopoulos","article-title":"Huntington disease: a single-gene degenerative disorder of the striatum","volume":"18","author":"PC Nopoulos","year":"2016","journal-title":"Dialogues in Clinical Neuroscience"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.neuron.2015.10.038","article-title":"RAN Translation in Huntington Disease","volume":"88","author":"M Banez-Coronel","year":"2015","journal-title":"Neuron"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.parkreldis.2014.12.013","article-title":"Update on Huntington&apos;s disease: advances in care and emerging therapeutic options","volume":"21","author":"D Zielonka","year":"2015","journal-title":"Parkinsonism & related disorders"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-160196","article-title":"Cerebrospinal Fluid Biomarkers for Huntington&apos;s Disease","volume":"5","author":"LM Byrne","year":"2016","journal-title":"Journal of Huntington's disease"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17530059.2012.701205","article-title":"Biomarkers for Huntington&apos;s disease: an update","volume":"6","author":"RI Scahill","year":"2012","journal-title":"Expert opinion on medical diagnostics"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1468-1331.2009.02808.x","article-title":"Cerebrospinal fluid biomarkers of white matter lesions\u2014cross-sectional results from the LADIS study","volume":"17","author":"M Jonsson","year":"2010","journal-title":"European journal of neurology"},{"issue":"15","key":"ref8","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1212\/WNL.0b013e3181a0fe3f","article-title":"Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis","volume":"72","author":"CE Teunissen","year":"2009","journal-title":"Neurology"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","article-title":"Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF","volume":"67","author":"LE Rosengren","year":"1996","journal-title":"Journal of neurochemistry"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1352458513490544","article-title":"Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis","volume":"20","author":"M Axelsson","year":"2014","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"issue":"16","key":"ref11","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1212\/WNL.0000000000001491","article-title":"Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis","volume":"84","author":"J Kuhle","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/mds.20979","article-title":"Diffusion tensor imaging in presymptomatic and early Huntington&apos;s disease: Selective white matter pathology and its relationship to clinical measures","volume":"21","author":"HD Rosas","year":"2006","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","author":"MG Spillantini","year":"2013","journal-title":"The Lancet Neurology"},{"issue":"Pt 4","key":"ref14","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/brain\/aww021","article-title":"Is Huntington&apos;s disease a tauopathy?","volume":"139","author":"M Gratuze","year":"2016","journal-title":"Brain: a journal of neurology"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.parkreldis.2008.05.012","article-title":"Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington&apos;s disease","volume":"15","author":"R Constantinescu","year":"2009","journal-title":"Parkinsonism & related disorders"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI80743","article-title":"Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington&apos;s disease patients","volume":"125","author":"EJ Wild","year":"2015","journal-title":"The Journal of clinical investigation"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1212\/NXI.0000000000000287","article-title":"Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease","volume":"3","author":"T Vinther-Jensen","year":"2016","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.parkreldis.2011.06.010","article-title":"Increased levels of total tau protein in the cerebrospinal fluid in Huntington&apos;s disease","volume":"17","author":"R Constantinescu","year":"2011","journal-title":"Parkinsonism & related disorders"},{"key":"ref19","article-title":"Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington&apos;s disease","author":"FB Rodrigues","year":"2016","journal-title":"Journal of neurochemistry"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/mds.26011","article-title":"Diagnostic criteria for Huntington&apos;s disease based on natural history","volume":"29","author":"R Reilmann","year":"2014","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington&apos;s Disease Rating Scale: reliability and consistency. Huntington Study Group","volume":"11","year":"1996","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.29.1.1","article-title":"Huntington disease: clinical care and evaluation","volume":"29","author":"I Shoulson","year":"1979","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0028-3932(68)90038-9","article-title":"Differential behavioural effects in frontal lobe disease","volume":"6","author":"AL Benton","year":"1968","journal-title":"Neuropsychologia"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/01688638708410764","article-title":"Episodic and semantic memory: a comparison of amnesic and demented patients","volume":"9","author":"N Butters","year":"1987","journal-title":"Journal of clinical and experimental neuropsychology: official journal of the International Neuropsychological Society"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410410521","article-title":"CAG repeat number governs the development rate of pathology in Huntington&apos;s disease","volume":"41","author":"JB Penney Jr.","year":"1997","journal-title":"Annals of neurology"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","article-title":"A new model for prediction of the age of onset and penetrance for Huntington&apos;s disease based on CAG length","volume":"65","author":"DR Langbehn","year":"2004","journal-title":"Clinical genetics"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","article-title":"Elevated neurofilament levels in neurological diseases","volume":"987","author":"N Norgren","year":"2003","journal-title":"Brain research"},{"issue":"3","key":"ref28","first-page":"231","article-title":"Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?","volume":"26","author":"K Blennow","year":"1995","journal-title":"Molecular and chemical neuropathology \/ sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"e0135886","DOI":"10.1371\/journal.pone.0135886","article-title":"Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction","volume":"10","author":"M Vagberg","year":"2015","journal-title":"PloS one"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13024-016-0130-3","article-title":"No diurnal variation of classical and candidate biomarkers of Alzheimer&apos;s disease in CSF","volume":"11","author":"C Cicognola","year":"2016","journal-title":"Molecular neurodegeneration"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0172762","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T17:55:10Z","timestamp":1658685310000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0172762"}},"subtitle":[],"editor":[{"given":"David","family":"Blum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,27]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0172762","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,27]]}}}